Anlon Healthcare IPO Closes with 3.67x Subscription, Grey Market Premium at Rs 5
Anlon Healthcare's IPO concluded with an overall subscription of 3.67 times. The retail segment saw the highest interest at 25.05x, followed by non-institutional investors at 2.72x and qualified institutional buyers at 1.01x. The Rs 121.03 crore issue offered 1.33 crore shares at a price band of Rs 86-91. The grey market premium suggests a potential listing price of Rs 96, indicating expected gains of 5.49%. Share allotment is scheduled for September 1, with listing on BSE and NSE set for September 3.
*this image is generated using AI for illustrative purposes only.
Anlon Healthcare's Initial Public Offering (IPO) concluded its subscription period today, marking the end of a significant milestone for the pharmaceutical intermediates manufacturer. The mainboard issue garnered substantial interest from investors across various categories.
Subscription Details
The IPO witnessed an overall subscription of 3.67 times, with investors bidding for 4,39,34,124 shares against the 1,33,00,000 shares on offer. Here's a breakdown of the subscription rates across different investor categories:
| Category | Subscription Rate |
|---|---|
| Retail Segment | 25.05x |
| Qualified Institutional Buyers | 1.01x |
| Non-Institutional Investors | 2.72x |
IPO Specifics
- Issue Size: Rs 121.03 crore
- Fresh Issue: 1.33 crore shares
- Price Band: Rs 86 - Rs 91 per share
Grey Market Premium
The grey market is showing a premium of Rs 5 for Anlon Healthcare shares. This suggests a potential listing price of Rs 96, compared to the upper price band of Rs 91, indicating expected gains of 5.49% for investors.
Key Dates
- Share Allotment: September 1
- Listing Date: September 3 (on BSE and NSE)
Company Profile
Anlon Healthcare, founded in 2013, specializes in the manufacture of high-purity pharmaceutical intermediates and active pharmaceutical ingredients. Their product portfolio caters to various sectors including:
- Medicines
- Nutraceuticals
- Personal care products
- Animal health products
The strong subscription numbers, particularly in the retail segment, suggest significant investor interest in Anlon Healthcare's business model and growth prospects. However, it's important to note that grey market premiums and subscription rates are not guaranteed indicators of future stock performance.
Investors and market watchers will be keenly observing the share allotment process on September 1 and the subsequent listing on September 3 on both the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
